Home/Pipeline/PercAssist eVAD™ System

PercAssist eVAD™ System

Temporary Mechanical Circulatory Support for Cardiogenic Shock/Heart Failure

Early FeasibilityActive

Key Facts

Indication
Temporary Mechanical Circulatory Support for Cardiogenic Shock/Heart Failure
Phase
Early Feasibility
Status
Active
Company

About PercAssist

PercAssist is pioneering a next-generation mechanical circulatory support (MCS) device that operates from outside the heart's chambers. Its eVAD™ System is an extravascular, intrapericardial device that compresses the heart in sync with its natural rhythm, offering potential biventricular support without the need for blood contact or systemic anticoagulation. The company has completed key preclinical studies and initiated early clinical programs in Europe and South America, targeting the large and growing population of patients with cardiogenic shock and advanced heart failure. With a strong IP portfolio and an experienced leadership team, PercAssist is positioned to address significant unmet needs in the MCS market.

View full company profile